Actinogen Medical LimitedASX: ACW

Application for quotation of securities - ACW

Sep 15, 2026 at 12:34 AM EDT · Issued by Actinogen Medical Limited via ASX

Filed with ASX · Sep 15, 2026 at 12:34 AM EDT · 7 pages · English

On 6ix: 6ix.com/news/application-for-quotation-of-securities-acw-2

Release

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 7Announcement SummaryEntity nameACTINOGEN MEDICAL LIMITEDAnnouncement TypeNew announcementDate of this announcementTuesday September 15, 2026The +securities to be quoted are:Total number of...

Actinogen Medical Limited on 6ix

Earlier from Actinogen Medical

Appendix 3Y-Dr Geoffrey BrookeSep 8
ACW CMO international Xanamem presentationSep 8
Response to ASX Price QuerySep 4
ACW unlisted options fully underwrittenAug 31
Proposed issue of securities - ACWAug 31

Later from Actinogen Medical

Notification of cessation of securities - ACWSep 15
ACW Alzheimers pivotal trial completes last patient visitSep 22
Options underwriting cleansing noticeSep 22
Underwriting of unlisted options completedSep 22
Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for NovemberSep 23

All Actinogen Medical news releases

Follow Actinogen Medical into a list and get an email when it puts out news.

Follow Actinogen Medical